MONSEY, N.Y., July 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Morphic Holding, Inc. (NASDAQ:MORF) ("Morphic") to Eli Lilly and Company ("Eli Lilly") for $57.00 per share in cash in a tender offer. The sales price is below the price target for Morphic of at least five Wall Street analysts (source: TipRanks).
If you remain a Morphic shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge:
https://wohlfruchter.com/cases/morphic-holding/
Alternatively, you may contact us by phone ...